Clinical trial
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis Having Chronic Inflammation
NCT03634475 is registered in ClinicalTrials.gov with Panoptes Pharma GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis Having Chronic Inflammation
- Lead sponsor
- Panoptes Pharma GmbH
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- April 30, 2019
- Enrollment
- 12 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
non-infectious uveitis